baber/WOPTO huggingface dataset:
Patent PT-2253500-E (PT)
Title: Device for temporary connection of a mobile object with a hold rail
Inventor: FISCHER THOMAS
Filed: 2010-05-07
Abstract: The device (1) has a holder (10) comprising a lever arm (12) pivoting around a rotation point (14) of the arm, where the arm is articulated by an articulated axis of a locking bolt (30) and an articulated axis of a clamping bolt (40). The locking bolts are displaced in an axial direction. The articulated axis of the locking bolt is arranged before the rotation point of the lever arm, and the articulated axis of the clamping bolt is arranged behind the rotation point of the lever arm. The locking and clamping bolts are moved in opposite directions by the lever arm.
Patent PT-559046-E (PT)
Inventor: ACKERMANN JEAN
IPC: C07D413/12
Filed: 1993-02-22
Abstract: The novel sulphonamidocarboxamides of the formula <IMAGE>  in which     X is a group of the formula X<1> or X<2>: <IMAGE>   T is CH2 or O, and A, M, Q and Y have the meaning given in the description, and hydrates or solvates thereof inhibit the platelet aggregation and clotting of fibrinogen in the plasma induced by thrombin. They are prepared by amidination of a cyclic amino group representing the group X or by C(O)Q amide formation.
Patent PT-649465-E (PT)
Inventor: HAILES ANNE MARIA
IPC: C12N9/02
Filed: 1993-05-28
Abstract: PCT No. PCT/GB93/01129 Sec. 371 Date Nov. 30, 1994 Sec. 102(e) Date Nov. 30, 1994 PCT Filed May 28, 1993 PCT Pub. No. WO94/00565 PCT Pub. Date Jan. 6, 1994A morphinone reductase enzyme and related process provide for the preparation of hydromorphone from morphinone and hydrocodone from neopinone or codeinone. The enzyme has no significant activity with compounds of similar ring structure, has a molecular weight of approximately 81 kilodaltons and is composed of two identical subunits. The enzyme uses NADH as a cofactor and displays no significant enzymatic activity in the reverse direction.
Patent PT-695544-E (PT)
Inventor: SAKUMA SATOSHI
IPC: A61K9/48
Filed: 1995-08-01
Abstract: Formulated hard gelatin capsules resistant to denaturation are described. The capsules contain 0.01 to 5 weight % of free radical scavenger for the whole amount of the content, whereby the decrease in solubility and the insolubilization can be prevented. The capsules still maintain stable drug releasing property.
Patent PT-861191-E (PT)
Inventor: LECOMTE MICHEL
IPC: B65F1/16
Filed: 1995-11-17
Abstract: PCT No. PCT/FR95/01520 Sec. 371 Date Nov. 4, 1998 Sec. 102(e) Date Nov. 4, 1998 PCT Filed Nov. 17, 1995 PCT Pub. No. WO97/18992 PCT Pub. Date May 29, 1997The invention relates to a device for wrapping contaminant or non-contaminant waste resulting from the medical treatment of humans or animals, as well as household waste. The device shown in FIG. 1 consists of a housing (1) used as a frame supporting a dispenser (2) for a heat-sealable plastic sleeve (3) forming a receptacle in which the waste may be deposited, a driving mechanism (4) for moving the sleeve, a heat-sealing mechanism (5), and a removable storage receptacle (6). The device is characterized in that the size of the wrapping may be selectively adapted to that of the waste objects. The device is useful for confining waste in wrappings that are impervious to volatile fumes, odours and liquids regardless of the position of the wrappings during storage and transport.
Patent PT-851932-E (PT)
Inventor: SHERRATT DAVID JOHN
IPC: C12N1/21
Filed: 1996-09-06
Abstract: A system is described which utilizes a novel system of repressor titration for maintenance of a plasmid useful in gene therapy and production of a recombinant protein. The system utilizes a transformed host cell containing a plasmid including an operator susceptible to binding by a repressor expressed in trans, a first chromosomal gene encoding the repressor, and a second chromosomal gene that is functionally associated with an operator and essential for cell growth, wherein the plasmid is present in the cell in sufficient numbers to titrate the repressor such that the essential gene is expressed, thereby permitting cell growth.
Patent PT-929713-E (PT)
Inventor: JOHANSSON HANS ERIK
IPC: D21F1/66
Filed: 1997-10-07
Abstract: Cellulosic fines and cellulosic fibers are separated from a suspension containing the fines, the fibers and hydrophobic materials by screening the suspension to remove the fibers, and then subjecting the resultant filtrate to dispersed air flotation in the presence of calcium and generally a separation aid to form an upper Reject fraction in which the hydrophobic material is concentrated and a lower Accept fraction in which the cellulosic fines are concentrated.
Patent PT-926080-E (PT)
Inventor: PRIETO DANY
IPC: B65D47/06
Filed: 1998-12-16
Abstract: The straw extraction device for a drinks can comprises a flexible plastic arm (4) with a ring at its end which fits around the straw (2) and which allows it to be moved from a position inside the can to a position where its top rests against the top of the can opening (5). A support arm (9) fixed between the side and top of the can cooperates with the first arm.
Patent PT-907547-E (PT)
Inventor: ARTMANN ULRICH
IPC: B62J7/06
Filed: 1998-03-26
Abstract: The invention relates to a luggage carrier for single track vehicles with suspension, comprising a luggage carrier frame with an area for accommodating luggage and at least two luggage carrier connections, at least one first connection (10) being provided for attachment on the suspended side of the vehicle. Known luggage carriers have the disadvantage that they cannot be used together with oscillating suspension elements without blocking the suspension effect. The aim of the invention is to create a luggage carrier for single track vehicles with suspension which has adequate support and stability. According to the invention, at least one second luggage carrier connection (11) is therefore provided for attachment to the non-suspended side of the vehicle, this second luggage carrier (11) being arranged so that it is moveable in the direction of the line of movement of the point of connection and fixed in the direction transverse to the line of movement. The inventive design allows the luggage carrier to be placed at different heights and especially, resist tilting moments, despite the presence of oscillating suspension elements.
Patent PT-988964-E (PT)
Inventor: PETER W MERZ DR
IPC: B60J10/00
Filed: 1999-09-22
Abstract: An adhesive assembly with two module adhesive layers between two bases and an elastic separating layer between the adhesive layers is new. Independent claims are included for: (1) A module for preparation of the adhesive assembly, the edge region of one base having an adhesive layer with a separating layer on it; (2) an adhesive layer is applied to the periphery of one base followed by a separating layer; (3) a separating layer is applied to the periphery of one base by means of an adhesive layer, giving a module, which can be further processed immediately, in some intermediate position, and/or after moving. A second adhesive layer is applied either to this module or to a second base, so that the second base and module are bonded together; (4) the elastic material is stretched so that it can be peeled off the adhesive layers resulting in separation of the adhesive assembly.
Patent SG-13492-G (SG)
Title: Multiple variable rate audio message recording and playback
IPC: H04N5/92
Filed: 1992-02-11
Abstract: Method and apparatus for recording and playing back a plurality of digitally encoded audio messages along with associated video data. The messages are combined along with a plurality of corresponding audio message initial data address signals and recorded on a recording medium with the video data. In playback, the address and audio data signals are retrieved from the recording medium and stored. The address signals are utilized to access selectable messages for decoding and playback with selected video data. Codes can be included to control the decoding rate in accordance with the sample rate of the audio message data.
Patent SG-32284-G (SG)
Title: Ideographic coding
IPC: G10L15/00
Filed: 1984-04-19
Abstract: Ideographic character selection and recording is accomplished by apparatus that encodes outputs of individually operable devices each corresponding to an unique character identifier component, for example phonetics. That encoding is used to address a data store containing whole characters or keys thereto organised in sets according to particular ones, preferably combinations, of the character identifier components. A limit of less than 7 device operations is envisaged for data store address completion. A visual display unit will then show all contents of a selected set for selection of the particular one character being entered by said devices. Data identifying that character is then added to an encoded multi- character message, and may simply be printed out locally or transmitted to some more sophisticated utilisation means, such as printing machinery or transmission facilities. <IMAGE>
Patent SG-57493-G (SG)
Title: Sample monitoring instrument for on-line application
IPC: G01N1/00
Filed: 1993-05-04
Abstract: An apparatus and method for on-line monitoring of a characteristic of a process liquid stream includes a cell for isolating a precise volume of the liquid. There are provided means for over-filling a sample chamber and means for removing the excess from the chamber comprising a downwardly extending drain line which terminates at a precisely positioned, downwardly facing inlet and means for applying negative pressure to the drain line to draw the excess liquid upwardly from the captured volume until the liquid level reaches the inlet and entry of air disrupts the liquid draining effect. The embodiment shown employs a closed volume, a vent, a conduit for delivery of process liquid into the cell under pressure and a syphon/drain line for removing excess liquid from the cell volume until there remains only a sample of accurately repeatable volume.
Patent IE-840212-L (IE)
Title: Primose oil, linolenic and linolenic acid derivatives as¹active agents
IPC: A23L35/00
Filed: 1984-01-30
Abstract: A pharmaceutical or dietary composition for use in the treatment of atopic disorders, including eczema, asthma, allergies (especially allergic rhinitis), migraine and disorders associated with atopy including Crohn's disease, ulcerative colitis, otitis media, nephrotic syndrome, or benign breast disease, or breast or other cancer, or diabetes, or alcoholism, comprising effective amounts of one or more of the metabolites of linoleic acid (GLA, DGLA, AA, 22:4n-6 or 22:5n-6) and one or more of the metabolites of  alpha -linolenic acid (18:4n-3, 20:4n-3, 20:5n-3, 22:5n-3 or 22:6n-3) as such or in the form of an ester, salt, amide or other derivative convertible in the body thereto alone or in an acceptable pharmaceutical carrier or diluent.
Patent IE-40829-L (IE)
Title: Tertiary alcohol stabilised e- series prostaglandins
IPC: A61K31/5575
Filed: 1975-03-14
Abstract: A stabilized pharmaceutical composition comprising an E-series prostaglandin and a saturated aliphatic tertiary alcohol having from 4 to 10 carbon atoms.
[US3927197A]
Patent IE-37674-L (IE)
Title: Combating blackgrass
IPC: A01N/
Filed: 1973-04-13
Abstract: 1430941 Combating blackgrass using trietazine FISONS LTD 9 April 1973 [22 April 1972 26 April 1972 18 May 1972 (2)] 18796/72 19252/72 23410/72 and 23411/72 Heading A5E A method of selectively combating blackgrass comprises applying to the locus 2-chloro- 4-diethylamino-6-ethylamino-1, 3, 5-triazine, optionally in conjunction with N'-(3, 4-dichlorophenyl)-N-methoxy-N-methyl urea or N-(benzothiazol-2-yl)-N, N'-dimethyl urea. Compositions for use in the method are claimed.
[GB1430941A]
Patent IE-44736-L (IE)
Title: Vaginal ring.
IPC: A61F6/02
Filed: 1977-04-06
Abstract: The present invention provides in a composite vaginal ring containing a safe and effective amount of a pharmaceutically active medicament which includes: a) a major supporting medicament-free vaginal ring consisting essentially of a physiolocigally acceptable synthetic resin and having at least a portion of the annular surface thereof adapted to mate with a corresponding minor, medicament-containing vaginal ring segment; and b) at least one minor, medicament-containing vaginal ring segment adapted to mate with the modified annular surface of said major supporting vaginal ring and consisting essentially of a safe and effective amount of a pharmaceutically active non-ionic, lipophilic drug dissolved or uniformly suspended in an elastomeric, cross-linked LTV linear dimethylpolysiloxane resin, the improvement wherein: at least one of the major supporting vaginal ring and the minor vaginal ring segment has a reniform or ellipsoidal cross section; or the major supporting vaginal ring is formed as a closed or inwardly open hollow-profile ring, as a closed or inwardly open hollow ring, as a hollow ring having a circular or reniform cross section, as a core-encased composite ring or as a sandwich element.
[CA1084792A]
Patent IE-880841-L (IE)
Title: Manufacturing wrapping paper
IPC: D21H23/02
Filed: 1988-03-22
Abstract: 1. Process for the manufacture of wrapping paper and of cardboard, characterized in that the following are added to the suspension containing the cellulose fibres before the sheet is formed : a) more than 0.5 parts by weight of cationic starch per 100 parts of cellulose fibres, b) less than 1 part by weigth, expressed as Al2 O3 , of aluminium polychloride per 100 parts of cellulose fibres.
Patent FI-814148-L (FI)
Inventor: ROCH JOSEF
IPC: C07D487/04
Filed: 1981-12-23
Abstract: Compounds of the formula   <IMAGE>   wherein R1 is optionally substituted alkyl; R2 is hydrogen or optionally substituted alkyl; or R1 and R2, together with each other and the nitrogen atom to which they are attached, form an optionally substituted cyclic imino group; R3 is an optionally substituted cyclic imino group; and R4 is substituted hydroxyl, mercapto or amino; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as antithrombotics.
Patent FI-843838-L (FI)
Inventor: GOMEZ DANIEL
IPC: B31B70/00
Filed: 1984-09-28
Abstract: New process for preparing a fiber sheet by using paper techniques, with a pH comprised between 6.2 and 9.5, from fibers, an organic polymer binder, an organic cationic flocculant and an agent reducing the adherence of the sheet to the wet presses during the formation of the sheet. The sheet obtained according to said method, of which the pH of the aqueous extract is higher than 7, and which exhibits improved mechanical properties particularly as to the tensile strength, the bursting resistance, the impact resistance, the rupture energy and the machinability, is useful in the packaging field and particularly for paper bags.
Patent FI-851943-L (FI)
Inventor: RELLERMEYER HEINRICH
IPC: C21C1/02
Filed: 1985-05-15
Abstract: A method and composition for desulfurization of hot metal is disclosed. To the hot metal there is added a composition comprising calcium carbide, a hydrogen releasing compound and magnesium.
Patent IE-44684-L (IE)
Title: Methyl-3-(2-qionoxalinylmethylene) carbazate-n1, n4-dioxides
IPC: A61P31/04
Filed: 1977-05-20
Abstract: The carbazates of formula I are obtained by reacting the quinoxaline N<1>,N<4>-dioxides carrying in position 2 a chloromethyl or bromomethyl group with one to two equivalents of an alkali metal carbonate and one to two equivalents of a hydrazine of formula R''NH-NH-COOCH3 at a temperature of between 75 and 85 DEG C and in an inert solvent. This hydrazine is prepared by reaction of methyl carbazate with a corresponding acid anhydride or sulphonyl halide which introduces the radical R''. The meaning of the symbols is explained in Claim 1. The compounds of formula I are strong antibacterial agents. <IMAGE>
[GB1591872A]
Patent IE-33572-L (IE)
Title: Erythromycylamine
IPC: C07H17/08
Filed: 1969-08-15
Abstract: 1275473 Erythromycin derivatives ELI LILLY & CO 29 Aug 1969 [29 Aug 1968] 43215/69 Heading C2A Erythromycylamine which melts at 125 to 127 C. and has the formula is prepared by catalytic hydrogenation of erythromycin oxime (IIa), erythromycin-hydrazine adduct (IIb) or the N<SP>1</SP>-isopropylidene derivative (IIc) of this adduct, which compounds have the general formula wherein R has the meanings The oxime and the hydrazine adduct are prepared by reacting erythromycin with hydroxylamine hydrochloride, and with hydrazine respectively, in a solvent such as methanol. The isopropylidene derivative is prepared by reacting the hydrazine adduct with acetone. These compounds are hydrogenated in an inert solvent such as acetic acid or preferably water containing 1 to 2% #-gluconolactone, glucoheptonolactone or other lactones of a sugar acid, using a noble metal catalyst such as platinum, palladium, ruthenium or rhodium, either as the free metal or the oxide. The oxime or hydrazine adduct are hydrogenated at about 500-2000 p.s.i., while pressures of 50-100 p.s.i. are preferably used in the caes of the isopropylidene derivative. By hydrogenating the isopropylidene derivative in a neutral medium, e.g. ethanol it may be converted to the corresponding N-isopropyl derivative of the erythromycin-hydrazine adduct. This represents an intermediate in the erythromycylamine formation and by further hydrogenation in an acidic medium the isopropyl derivative yields erythromycylamine. Pharmaceutical compositions having antibacterial activity against Gram-positive and Gramnegative micro-organisms comprise the antibiotic erythromycylamine together with a pharmaceutically acceptable diluent or carrier.
[GB1275473A]
Patent IE-41371-L (IE)
Title: Lincomycin production
IPC: C12P1/06
Filed: 1975-05-30
Abstract: Microbiological process for preparing the antibiotic lincomycin at temperatures ranging from 18 DEG C. to 45 DEG C. using the newly discovered microorganism Streptomyces vellosus. The subject process advantageously results in the preparation of lincomycin without the concomitant production of lincomycin B (4'-depropyl-4'-ethyllincomycin). The absence of lincomycin B production results in increased lincomycin recovery efficiency.
[US4271266A]
Patent IE-45108-L (IE)
Title: Vitamin product
IPC: A23K20/163
Filed: 1977-06-24
Abstract: The invention relates to a vitamin product. [FR2355462A1]
Patent IE-801596-L (IE)
Title: Benzothiophenes
IPC: C07D333/64
Filed: 1980-07-30
Abstract: Compounds of the formula   <IMAGE>   wherein Ar is phenyl; mono- or di-substituted phenyl, where the substituents are one to two halogens, one to two alkyls of 1 to 3 carbon atoms, or one amino, nitro, cyano or trifluoromethyl; or pyridinyl; R is hydrogen, chlorine, methyl or methoxy; R1 is hydrogen or methyl; R2 is hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, cycloalkyl of 3 to 8 carbon atoms, methyl-(cycloalkyl of 3 to 8 carbon atoms) or -A-R4, where A is alkylene of 2 to 3 carbon atoms, and R4 is hydroxyl, methylamino, dimethylamino, N-methyl-ethylamino, diethylamino, pyrrolidino, piperidino, hexamethyleneimino, morpholino or 4-methyl-1-piperazinyl; or R1 and R2, together with each other and the nitrogen atom to which they are attached, form a 4- to 7-membered, saturated or mono-unsaturated, unsubstituted or substituted heterocycle which may contain nitrogen, oxygen, sulfur, sulfinyl or sulfonyl as additional ring members, where the substituents are alkyls of 1 to 3 carbon atoms. The compounds are useful as anticonvulsants.
Patent IE-41506-L (IE)
Title: Manufacture of 2-imino-3-(2-chloro-2-phenyl-ethyl)¹thiazolidine and tetramisole.
IPC: C07D277/18
Filed: 1975-07-25
Abstract: 1493373 Thiazolidine derivative IMPERIAL CHEMICAL INDUSTRIES Ltd 24 July 1975 [13 Aug 1974] 35594/74 Heading C2C 2 - Imino - 3 - (2 - chloro - 2 - phenyl - ethyl) thiazolidine and acid addition salts thereof are prepared by reacting 2-imino-3-(2-hydroxy-2- phenylethyl) thiazolidine, or an acid addition salt thereof, with chlorosulphonic acid and either aqueous hydrochloric acid or water. The chlorosulphonic acid may be generated in situ from sulphuryl chloride. The process is preferably carried out in a closed vessel or apparatus which prevents the loss of the hydrogen chloride gas which is produced at the beginning of the process. The products may be ring- closed to form tetramisole (dl-2,3,5,6-tetrahydro- 6-phenyl-imidazo[2,1-b]thiazolo) which has anthelmintic activity.
[GB1493373A]
Patent IE-881778-L (IE)
Title: New amino acid derivatives, processes for the preparation¹thereof and pharmaceutical composition comprising the same
IPC: A61K31/54
Filed: 1988-06-13
Abstract: A compound of the formula : <CHEM> wherein R<1> is lower alkyl optionally substituted with a substituent selected from the group consisting of acyl,hydroxy, lower alkoxy, aryl, lower alkylthio and a group of the formula : <CHEM> in which R<5> is hydrogen or acyl and R<6> is hydrogen or lower alkyl; aryl; or amino optionally substituted with substituent(s) selected from the group consisting of lower alkyl and acyl; and R<2> is hydrogen or lower alkyl; or R<1> and R<2> are taken together with the attached nitrogen atom to form a heterocyclic group optionally substituted with substituent(s) selected from the group consisting of lower alkyl, hydroxy(lower)alkyl, lower alkoxy(lower)alkyl, acyl(lower)alkyl, oxo and acyl; R<3> is hydrogen or lower alkyl; and R<4> is lower alkyl; and its pharmaceutically acceptable salt, processes for the preparation thereof and pharmaceutical composition comprising the same.
[EP0300189A2]
Patent IE-42988-L (IE)
Title: Sintered inserts in aluminium articles
IPC: F02F3/08
Filed: 1975-08-22
Abstract: A metal article is formed by a sintered body of an austenitic ferrous alloy containing chromium and nickel, the ferrous alloy having been infiltrated with a copper or copper base alloy during or after sintering of the body.
[US4008051A]
Patent IE-41851-L (IE)
Title: Pyrophosphate-silicate detergent composition
IPC: C11D3/10
Filed: 1975-09-29
Abstract: The composition consists of (1) 20 to 100% by weight of a homogeneous granular surfactant material in the form of homogeneous particles, (2) 0 to 60% by weight of an alkaline sodium and/or potassium pyrophosphate and (3) 0 to 80% by weight of diluent. The surfactant material contains (a) 1 to 30% by weight of a silicate of the formula SiO2:M2O, (b) 0 to 60% by weight of a pyrophosphate of the formula MaHb(P2O7) and (c) 1 to 50% by weight of at least one anionic, non-ionic, zwitterionic and/or ampholytic surfactant. M, a and b in the formulae have the meanings stated in Claim 1. The SiO2:M2O molar ratio in the silicate (a) is 1.6:1 to 4:1. When 1.2 g of the detergent and cleaning composition are added to 1 litre of distilled water at 25 DEG C, stirred for 1 minute and filtered under a nitrogen pressure of 6.8 atm through a filter with a diameter of 142 mm and a pore size of 5 mu m, the molar ratio of filtrate SiO2 to total SiO2 from the silicate is not more than 3.3:4. The detergent and cleaning composition contains a total of 5 to 60% by weight pyrophosphate. The total amount of alkali metal tripolyphosphate (if present) is usually less than 20% by weight of the total pyrophosphate. The detergent and cleaning composition can additionally contain 1 to 40%, based on the dry weight, of a synthetic, water-insoluble, hydrated alumosilicate of the formula Naz[(AlO2)z.(SiO2)y]xH2O or of an amorphous alumosilicate of the formula Nam(mAlO2.nSiO2) or 0.1 to 4% by weight of a glassy phosphate of the formula (Me2O)p(P2O5)q. Me, m, n, p, q, x, y and z in the formulae have the meanings stated in Claims 15, 16 and 17. Despite its reduced phosphorus content, the detergent and cleaning composition has a good cleansing action in hard water.
[GB1518286A]
Patent IE-832194-L (IE)
Title: Improved strain of clostridium acetobutylicum
IPC: C12P7/28
Filed: 1983-09-19
Abstract: A process for preparing a novel, improved strain of solvent-producing Clostridium is disclosed. A spore-forming parent strain is grown in a continuous culturing reactor under conditions which provide a strain that gives improved yields of solvents in a shorter time than does the parent strain. 
[EP0111683A1]